SAN DIEGO -- Among patients with schizophrenia, most preferred long-acting injectable antipsychotics when given a choice, a researcher reported here. A post-hoc analysis of a randomized, controlled ...
Patients with schizophrenia appear to prefer long-acting injectable (LAI) antipsychotics compared with oral versions of these medications primarily because injectables are more convenient and give ...
Psychiatric medications are no panacea. Recent studies have raised questions, for instance, about whether antidepressants are really any better than placebo pills. While I still believe that ...
Please provide your email address to receive an email when new articles are posted on . Fewer than 2% of patients who received long-acting injectable antipsychotics were readmitted vs. 8.3% of those ...
Among adults with schizophrenia or schizoaffective disorder, treatment with the newer, more costly antipsychotic paliperidone palmitate, compared with the older antipsychotic haloperidol decanoate, ...
Teva announces positive real-world outcomes for UZEDY® and TEV-'749 in schizophrenia treatment, highlighting improved adherence and reduced hospital visits. Teva Pharmaceuticals has announced positive ...
COLORADO SPRINGS, Colorado — The long-term formulation of the antipsychotic paliperidone (Invega, Janssen Pharmaceuticals, Inc) significantly delays relapse in schizophrenia patients with no increase ...
MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: MedinCell (Paris:MEDCL): A second long-acting injectable antipsychotic using MedinCell's technology has received FDA IND * clearance to initiate ...
Nuechterlein said the next stage of the research will be examining whether there are additional benefits of a long-acting injectable antipsychotic medication, and if it is just as effective if given ...
Long-Acting Injectable Antipsychotics in First-Episode Schizophrenia Long-acting injectable (LAI) antipsychotics may improve medication adherence and reduce relapse in patients with schizophrenia.
One of the most important goals in the treatment of people with schizophrenia is preventing relapses, which often lead to periods of hospitalization. Discontinuing Medication Can Cause Relapse in ...
One of the most important goals in the treatment of people with schizophrenia is preventing relapses, which often lead to periods of hospitalization. Discontinuing Medication Can Cause Relapse in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results